{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:39:12Z","timestamp":1791405552272,"version":"4.3.3"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,3,15]]},"DOI":"10.1097\/01.tp.0000441362.11232.48","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T11:47:34Z","timestamp":1391168854000},"page":"494-501","source":"Crossref","is-referenced-by-count":78,"title":["Impact of IgM and IgG3 Anti-HLA Alloantibodies in Primary Renal Allograft Recipients"],"prefix":"10.1097","volume":"97","author":[{"given":"Matthew J.","family":"Everly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorita M.","family":"Rebellato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl E.","family":"Haisch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly P.","family":"Briley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Bolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William T.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott A.","family":"Kendrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Q.","family":"Maldonado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert C.","family":"Harland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul I.","family":"Terasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-5-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/TP.0b013e31817c4cb8","article-title":"Human leukocyte antigen antibodies and chronic rejection: from association to causation.","volume":"86","author":"Terasaki","year":"2008","journal-title":"Transplantation"},{"key":"R2-5-20210129","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1111\/j.1600-6143.2009.02799.x","article-title":"Antibody-mediated microcirculation injury is the major cause of late kidney transplant failure.","volume":"9","author":"Einecke","year":"2009","journal-title":"Am J Transplant"},{"key":"R3-5-20210129","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","article-title":"Incidence and impact of de novo donor-specific alloantibody in primary renal allografts.","volume":"95","author":"Everly","year":"2013","journal-title":"Transplantation"},{"key":"R4-5-20210129","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/TP.0b013e3182139da1","article-title":"Inferior kidney allograft outcomes in patients with de novo donor-specific antibodies are due to acute rejection episodes.","volume":"91","author":"Cooper","year":"2011","journal-title":"Transplantation"},{"key":"R5-5-20210129","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.2012.190","article-title":"Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.","volume":"82","author":"DeVos","year":"2012","journal-title":"Kidney Int"},{"issue":"Suppl 3","key":"R7-5-20210129","first-page":"227","article-title":"Five year outcomes of positive crossmatch kidney transplants: insight into late graft injury.","volume":"12","author":"Bentall","year":"2012","journal-title":"Am J Transplant"},{"key":"R8-5-20210129","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/TP.0b013e3182a289ac","article-title":"Trends and characteristics in early glomerular filtration rate decline after posttransplantation alloantibody appearance.","volume":"96","author":"Wu","year":"2013","journal-title":"Transplantation"},{"issue":"Suppl 6","key":"R9-5-20210129","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1034\/j.1399-0012.2001.00005.x","article-title":"IgM antibodies identified by a DTT-ameliorated positive crossmatch do not influence renal graft outcome but the strength of the IgM lymphocytotoxicity is associated with DR phenotype.","volume":"15","author":"Bryan","year":"2001","journal-title":"Clin Transplant"},{"key":"R10-5-20210129","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1097\/00007890-199912270-00007","article-title":"Flow cytometry-detected IgG is not a contraindication to renal transplantation: IgM may be beneficial to outcome.","volume":"68","author":"Kerman","year":"1999","journal-title":"Transplantation"},{"key":"R11-5-20210129","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/S0198-8859(03)00065-X","article-title":"The detection and definition of IgM alloantibodies in the presence of IgM autoantibodies using flowPRA beads.","volume":"64","author":"Khan","year":"2003","journal-title":"Hum Immunol"},{"key":"R12-5-20210129","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/lt.20062","article-title":"Protective anti-donor IgM production after crossmatch positive liver-kidney transplantation.","volume":"10","author":"McAlister","year":"2004","journal-title":"Liver Transpl"},{"key":"R13-5-20210129","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.humimm.2009.04.017","article-title":"Role of immunoglobulin (Ig)-G and IgM antibodies against donor human leukocyte antigens in organ transplant recipients.","volume":"70","author":"Stastny","year":"2009","journal-title":"Hum Immunol"},{"key":"R14-5-20210129","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1161\/CIRCULATIONAHA.104.485003","article-title":"Immunoglobulin M-to-immunoglobulin G anti-human leukocyte antigen class II antibody switching in cardiac transplant recipients is associated with an increased risk of cellular rejection and coronary artery disease.","volume":"112","author":"Lietz","year":"2005","journal-title":"Circulation"},{"key":"R15-5-20210129","first-page":"809","article-title":"Immunoglobulin class and specificity of lymphocytotoxic antibodies after kidney transplantation.","volume":"3","author":"Marcen","year":"1988","journal-title":"Nephrol Dial Transplant"},{"key":"R16-5-20210129","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1111\/j.1600-6143.2005.01016.x","article-title":"Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure.","volume":"5","author":"Mizutani","year":"2005","journal-title":"Am J Transplant"},{"key":"R17-5-20210129","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1097\/TP.0b013e3182888db6","article-title":"The role of immunoglobulin-G subclasses and C1q in de novo HLA-DQ donor-specific antibody kidney transplantation outcomes.","volume":"95","author":"Freitas","year":"2013","journal-title":"Transplantation"},{"key":"R18-5-20210129","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.23451","article-title":"Donor-specific human leukocyte antigen antibodies of the immunoglobulin G3 subclass are associated with chronic rejection and graft loss after liver transplantation.","volume":"18","author":"Kaneku","year":"2012","journal-title":"Liver Transpl"},{"key":"R19-5-20210129","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ki.2010.556","article-title":"Surveillance of alloantibodies after transplantation identifies the risk of chronic rejection.","volume":"79","author":"Kimball","year":"2011","journal-title":"Kidney Int"},{"key":"R21-5-20210129","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R22-5-20210129","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1097\/TP.0b013e31824612df","article-title":"Durability of antibody removal following proteasome inhibitor-based therapy.","volume":"93","author":"Everly","year":"2012","journal-title":"Transplantation"},{"key":"R23-5-20210129","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2011.03640.x","article-title":"Revisiting traditional risk factors for rejection and graft loss after kidney transplantation.","volume":"11","author":"Dunn","year":"2011","journal-title":"Am J Transplant"},{"key":"R24-5-20210129","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S0140-6736(12)61265-3","article-title":"Antibody-mediated vascular rejection of kidney allografts: a population-based study.","volume":"381","author":"Lefaucheur","year":"2013","journal-title":"Lancet"},{"key":"R25-5-20210129","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1126\/science.1201730","article-title":"Different B cell populations mediate early and late memory during an endogenous immune response.","volume":"331","author":"Pape","year":"2011","journal-title":"Science"},{"key":"R26-5-20210129","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.1002836","article-title":"IgM production by bone marrow plasmablasts contributes to long-term protection against intracellular bacterial infection.","volume":"186","author":"Racine","year":"2011","journal-title":"J Immunol"},{"key":"R27-5-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Mycophenolate Mofetil Investigators.","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"R28-5-20210129","first-page":"278","article-title":"Regulation of human IgG subclass production by cytokines: human IgG subclass production enhanced differentially by interleukin-6.","volume":"84","author":"Kawano","year":"1995","journal-title":"Immunology"},{"key":"R29-5-20210129","doi-asserted-by":"crossref","first-page":"8119","DOI":"10.1128\/IAI.73.12.8119-8129.2005","article-title":"Epitope-specific regulation of immunoglobulin class switching in mice immunized with malarial merozoite surface proteins.","volume":"73","author":"Tongren","year":"2005","journal-title":"Infect Immun"},{"key":"R30-5-20210129","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1034\/j.1600-6143.2003.00072.x","article-title":"Antibody-mediated rejection criteriaan addition to the Banff 97 classification of renal allograft rejection.","volume":"3","author":"Racusen","year":"2003","journal-title":"Am J Transplant"},{"key":"R31-5-20210129","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1600-6143.2006.01688.x","article-title":"Banff 05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy (`CAN).","volume":"7","author":"Solez","year":"2007","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/01.TP.0000441362.11232.48","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:03:36Z","timestamp":1620936216000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201403150-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,15]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1097\/01.tp.0000441362.11232.48","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2014,3,15]]}}}